Certolizumab pegol Active Not Recruiting Phase 1 Trials for Adenocarcinoma of Lung Stage IV Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02120807Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas